St. Joseph Mercy Oakland in Pontiac, Michigan, is the first hospital certified by the Joint Commission as a thrombectomy-capable stroke center (TSC), according to a March 21 press release.
Edwards Lifesciences Corporation today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve.
Patient satisfaction and physician ratings are directly influenced by wait times before appointments, Vitals’ ninth annual wait time report suggests. Thirty percent of patients have walked out of an appointment due to a long wait, while 20 percent said they’ve changed doctors because of wait times.
It’s not just the meat you eat that impacts your risk of developing high blood pressure—but how you cook it, according to research presented March 21 at the American Heart Association’s Epidemiology and Prevention/Lifestyle and Cardiometabolic Health scientific sessions in New Orleans.
Current clinical guidelines recommend implantable cardioverter-defibrillators (ICDs) in survivors of sudden cardiac arrest (SCA), except when the cause of the SCA is deemed reversible. But a new study in Circulation: Arrhythmia and Electrophysiology demonstrates that many of these patients gain a survival benefit from ICDs as well.
Avid Star Wars fan Austin Eggleston, a 15-year-old heart transplant hopeful, finally received the news he was going to receive a new heart from Chewbacca, the big, furry character from a galaxy far, far away.
The hearts of adults who are born prematurely don’t function as well during exercise, possibly explaining why they’re more at risk for early heart failure, according to a study published March 19 in the Journal of the American College of Cardiology.
Lesbian, gay and bisexual adults are likely to have poor cardiovascular health compared to heterosexual counterparts, according to findings presented March 20 at the American Heart Association’s Epidemiology and Lifestyle conference in New Orleans.
Continuous anticoagulation with apixaban during atrial fibrillation (AFib) ablation was found to be as safe as warfarin and other vitamin K antagonists (VKAs) in a randomized trial of 633 patients.
The case for PCSK9 inhibitors is strong following the American College of Cardiology’s 67th annual symposium in Orlando, Florida, but some physicians remain wary of the medication, citing gaps in clinical evidence and questioning if cardiology is ready for the widespread distribution of such pricey drugs.
